| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.5 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |